您要查找的是不是:
- MIXED過程Mixed procedure
- MIXED-CONTROLMIXED-CONTROL
- mixed congruence method (計算數學)混合同余法
- mixed hyperlipoproteinemia type Ⅰ and Ⅳ高乳糜微粒血癥及前β脂蛋白增高(Ⅰ型和Ⅳ型混合型高脂蛋白血癥, 即Ⅴ型高脂蛋白血癥)
- mixed capillarycavernous hemangioma混合性毛細血管-海綿狀血管瘤
- mixed cellularity type of Hodgkins disease混合型何杰金氏病
- Mixed-HSCT后應用DLI+IL-2,可能是有效提高長期生存率的免疫生物治療措施之一。Immuno-biotherapy with DLI +IL-2 after Mixed-HSCT in patients of acute myelogenous leukemia may be a method to increase DFS efficiently.
- 在理解切換到SQL Server Mixed Mode安全性的安全意義之前,最好保留為默認模式。It's a good idea to leave the default until you understand the security implications of switching to SQL Server Mixed Mode security.
- 經過1~5年觀察,8例患者Mixed-HSCT后應用DLI+IL-2治療的患者長期生存率為62.5%。Result DFS in 8 cases of patients with acute myelogenous leukemia received Mixed-HSCT and treated with DLI +IL-2 for 2-7 times were 62.5%25. There were no GVHD.
- mixed -HSCT :19/ 3 3例 (2 4.2% )復發死亡 ; 6/ 3 3例 (18.2% )移植相關死亡 ;mixed-HSCT:8/33(24.2%25) patients died from TRM and 6/33(18.2%25)from relapse;
- 如果您想用另一個用戶名密碼對進行SQL Server認證,請選擇Mixed Mode并輸入適當的信息。If you want to have a different username password pair for SQL Server Authentication, select Mixed Mode and enter the appropriate information.
- 方法8例急性髓性白血病患者在完全緩解期實施了Mixed-HSCT,于造血恢復后,給予DLI+IL-2治療2~7次,并隨訪觀察臨床療效。MethodAfter times of chemotherapy,8 cases of patients with acute myelogenous leukemia received Mixed-HSCT,then were treated with DLI +IL-2 for 2-7 times.
- Mixed過程提供了豐富的協方差結構,可以充分利用重復測量資料的信息,又能處理缺失值,是重復測量資料最優的統計分析方法。And the MIXED procedure of the SAS System provides a rich selection of covariance structures through the RANDOM and REPEATED statements.
- 本文提出了一種簡單的可擴展性QoS路由算法Single Mixed Metric based on Link-States,簡稱SMM_LS算法,是改進的Dijk-stra算法。This paper proposes a simple scalable QoS routing algorithm-single mixed metric based on link_states, SMM_LS for short, which is a modified Dijkstra algorithm.
- 目的探討急性髓性白血病在經過混合造血干細胞移植(mixed-HSCT)后,應用供體淋巴細胞輸注(DLI)+白介素-2(IL-2)作為后續免疫生物治療措施的意義。Objective To approach curative effect of using DLI +IL-2 as immunobiotherapy after Mixed-HSCT in acute myelogenous leukemia.